Standard for anti-SARS-CoV-2 immunoglobulin

SARS-CoV-2 antibodies

Covid-19 vaccine developers are using a range of immunoassays with different readouts to measure immune responses after vaccination, making comparisons of the immunogenicity of different vaccine candidates challenging. A large collaborative study was launched in July, 2020, to test serum samples and plasma samples sourced from convalescent patients with the aim of selecting the most suitable candidate material for an International Standards for anti-SARS-CoV-2. [...]

Create an account and
get free access to full portal features

Choose an option to sign up

Register with Facebook Register with Google Register with your email

The portal

Our goal is to keep you informed on COVID-19 with only the most accurate, fact-check news.

Support our Foundation and work on the #COVID-ACTION project.